Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (61)
Lei Yan, Ruoqi Li, Dijun Li, Yuanyuan Zhu, Zhi Lv & Bin Wang. (2023) Development of a novel vasculogenic mimicry-associated gene signature for the prognostic assessment of osteosarcoma patients. Clinical and Translational Oncology 25:12, pages 3501-3518.
Crossref
Crossref
Valentina Artusa, Luana Calabrone, Lorenzo Mortara, Francesco Peri & Antonino Bruno. (2023) Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory. International Journal of Molecular Sciences 24:5, pages 4997.
Crossref
Crossref
Yongwen Luo, Zhonghua Yang, Ying Yu & Peng Zhang. (2022) HIF1α lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer. International Journal of Biological Macromolecules 222, pages 2225-2243.
Crossref
Crossref
Elena Andreucci, Silvia Peppicelli, Jessica Ruzzolini, Francesca Bianchini & Lido Calorini. (2022) Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry. Cancer and Metastasis Reviews 41:4, pages 935-951.
Crossref
Crossref
Deok-Soo Han, Hyo-Jeong Lee & Eun-Ok Lee. (2022) Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells. Scientific Reports 12:1.
Crossref
Crossref
Molly S. Myers, Elizabeth A. Kosmacek, Arpita Chatterjee & Rebecca E. Oberley-Deegan. (2022) CT vs. bioluminescence: A comparison of imaging techniques for orthotopic prostate tumors in mice. PLOS ONE 17:11, pages e0277239.
Crossref
Crossref
Hengmin Han, Seon-Ok Lee, Yinzhu Xu, Jung-Eun Kim & Hyo-Jeong Lee. (2022) SPHK/HIF-1α Signaling Pathway Has a Critical Role in Chrysin-Induced Anticancer Activity in Hypoxia-Induced PC-3 Cells. Cells 11:18, pages 2787.
Crossref
Crossref
Liwei Ruan, Songou Zhang, Xiaozhen Chen, Wenqing Liang & Qiong Xie. (2022) Role of anti-angiogenic factors in the pathogenesis of breast cancer: A review of therapeutic potential. Pathology - Research and Practice 236, pages 153956.
Crossref
Crossref
Hadi Chavoshi, Neda Poormolaie, Vahid Vahedian, Hamid Kazemzadeh, Amirabbas Mir, Hamid Reza Nejabati, Javad Behroozi, Alireza Isazadeh, Saba Hajezimian, Mohammad Nouri & Nazila Fathi Maroufi. (2022) Vascular mimicry: A potential therapeutic target in breast cancer. Pathology - Research and Practice 234, pages 153922.
Crossref
Crossref
Depanwita Saha, Debarpan Mitra, Neyaz Alam, Sagar Sen, Saunak Mitra Mustafi, Syamsundar Mandal, Biswanath Majumder & Nabendu Murmu. (2022) Orchestrated expression of vasculogenic mimicry and laminin‐5γ2 is an independent prognostic marker in oral squamous cell carcinoma. International Journal of Experimental Pathology 103:2, pages 54-64.
Crossref
Crossref
Ming Wang, Shanfa Ren, Zhun Bi, Liang Zhang, Mengqi Cui, Ronghao Sun, Jiali Bao, Dandi Gao, Bo Yang, Xiaoping Li, Mingjiang Li, Ting Xiao, Hong‐gang Zhou & Cheng Yang. (2022)
Myricetin reverses epithelial–endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting
PAR1
. Phytotherapy Research 36:4, pages 1807-1821.
Crossref
Crossref
Jing-yue Zhang, Yu Du, Li-ping Gong, Yi-ting Shao, Jing-yun Wen, Li-ping Sun, Dan He, Jin-rui Guo, Jian-ning Chen & Chun-kui Shao. (2022) EBV-Induced CXCL8 Upregulation Promotes Vasculogenic Mimicry in Gastric Carcinoma via NF-κB Signaling. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Ying Shao & Bingjian Lu. (2021) The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers. Cancer and Metastasis Reviews 41:1, pages 173-191.
Crossref
Crossref
Deok-Soo Han & Eun-Ok Lee. (2022) Sp1 Plays a Key Role in Vasculogenic Mimicry of Human Prostate Cancer Cells. International Journal of Molecular Sciences 23:3, pages 1321.
Crossref
Crossref
Tobiloba C. Elebiyo, Damilare Rotimi, Ikponmwosa O. Evbuomwan, Rotdelmwa Filibus Maimako, Matthew Iyobhebhe, Oluwafemi Adeleke Ojo, Olarewaju M. Oluba & Oluyomi S. Adeyemi. (2022) Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy. Cancer Treatment and Research Communications 32, pages 100620.
Crossref
Crossref
Tanya N. Augustine, Ekene Emmanuel Nweke & Pascaline N. Fru. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
25
.
Joseph C. Manarang & Alison McDermott. 2022. Vasculogenic Mimicry. Vasculogenic Mimicry
129
139
.
Saber Imani, Shuya Liu, Mazaher Maghsoudloo & QingLian Wen. 2022. Vasculogenic Mimicry. Vasculogenic Mimicry
107
120
.
Jordan A. Harry & Mark L. Ormiston. (2021) Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Marcella Massimini, Mariarita Romanucci, Raffaella De Maria & Leonardo Della Salda. (2021) An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology. Frontiers in Veterinary Science 8.
Crossref
Crossref
Rohit Siddhartha & Minal Garg. (2021) Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions. Toxicology and Applied Pharmacology 426, pages 115593.
Crossref
Crossref
Lucas Treps, Sébastien Faure & Nicolas Clere. (2021) Vasculogenic mimicry, a complex and devious process favoring tumorigenesis – Interest in making it a therapeutic target. Pharmacology & Therapeutics 223, pages 107805.
Crossref
Crossref
Huan Wang, Liya Wang, Qiming Zheng, Zeyi Lu, Yuanlei Chen, Danyang Shen, Dingwei Xue, Minxiao Jiang, Lifeng Ding, Jie Zhang, Haiyang Wu, Liqun Xia, Jun Qian, Gonghui Li & Jieyang Lu. (2021)
Oncometabolite
L‐2‐hydroxyglurate
directly induces vasculogenic mimicry through
PHLDB2
in renal cell carcinoma
. International Journal of Cancer 148:7, pages 1743-1755.
Crossref
Crossref
Konrad Sopyllo, Andrew M. Erickson & Tuomas Mirtti. (2021) Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer. Cancers 13:4, pages 628.
Crossref
Crossref
Qingxi Luo, Jun Wang, Wenyuan Zhao, Zhenzi Peng, Xianyu Liu, Bin Li, Heng Zhang, Bin Shan, Chunfang Zhang & Chaojun Duan. (2020) Vasculogenic mimicry in carcinogenesis and clinical applications. Journal of Hematology & Oncology 13:1.
Crossref
Crossref
Nazila Fathi Maroufi, Sina Taefehshokr, Mohammad-Reza Rashidi, Nima Taefehshokr, Mahdieh Khoshakhlagh, Alireza Isazadeh, Narmin Mokarizadeh, Behzad Baradaran & Mohammad Nouri. (2020) Vascular mimicry: changing the therapeutic paradigms in cancer. Molecular Biology Reports 47:6, pages 4749-4765.
Crossref
Crossref
Zhao Yang, Jiaqi Chen, Hongjun Xie, Tianjie Liu, Yule Chen, Zhenkun Ma, Xinqi Pei, Wenjie Yang & Lei Li. (2020) Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation. Cancer Letters 473, pages 118-129.
Crossref
Crossref
Julie-Ann Hulin, Ekaterina A. Gubareva, Natalia Jarzebska, Roman N. Rodionov, Arduino A. Mangoni & Sara Tommasi. (2020) Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer. Frontiers in Oncology 9.
Crossref
Crossref
Stephen L. Wechman, Luni Emdad, Devanand Sarkar, Swadesh K. Das & Paul B. Fisher. 2020.
27
67
.
Debarpan Mitra, Sayantan Bhattacharyya, Neyaz Alam, Sagar Sen, Saunak Mitra, Syamsundar Mandal, Shivani Vignesh, Biswanath Majumder & Nabendu Murmu. (2019) Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast. Breast Cancer Research and Treatment 179:2, pages 359-370.
Crossref
Crossref
Yue-tao Zhou, Wei-wei Cai, Yue Li, Xiao Jiang, Lei Feng, Qiao-ying Zhu, Yan-ling Liu, Yu-xiao Chen, Shuang-shuang Li, Bin Du, Florian Lang, Peng-xi Wu & Li-ying Qiu. (2019) Correlations between quantitative parameters of contrast-enhanced ultrasound and vasculogenic mimicry in murine tumor model: a novel noninvasive technique for assessment?. Biological Procedures Online 21:1.
Crossref
Crossref
Jun Da, Mingxi Xu, Yiwei Wang, Wenfeng Li, Mujun Lu & Zhong Wang. (2019) Kaempferol Promotes Apoptosis While Inhibiting Cell Proliferation via Androgen-Dependent Pathway and Suppressing Vasculogenic Mimicry and Invasion in Prostate Cancer. Analytical Cellular Pathology 2019, pages 1-10.
Crossref
Crossref
Hee Sung Kim, You Jin Won, Ju Hee Shim, Hyun Ji Kim, Jihun Kim, Hea Nam Hong & Byung Sik Kim. (2019) Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma. Scientific Reports 9:1.
Crossref
Crossref
Changhwan Yeo, Hyo-Jeong Lee & Eun-Ok Lee. (2019) Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells. Life Sciences 221, pages 267-273.
Crossref
Crossref
Ting Xiao, Qiang Zhang, Shumin Zong, Wei-long Zhong, Yuan Qin, Zhun Bi, Shuang Chen, Hui-juan Liu, Jun-jie Wei, Bi-jiao Zhou, Lu-meng Wang, Hong-gang Zhou, Yan-rong Liu, Tao Sun & Cheng Yang. (2018) Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Tong Xiang, Yu-Xin Lin, Wenlong Ma, Hao-Jiong Zhang, Ke-Ming Chen, Gui-Ping He, Xiao Zhang, Miao Xu, Qi-Sheng Feng, Ming-Yuan Chen, Mu-Sheng Zeng, Yi-Xin Zeng & Lin Feng. (2018) Vasculogenic mimicry formation in EBV-associated epithelial malignancies. Nature Communications 9:1.
Crossref
Crossref
Hua Wang, Bin Huang, Bai Mou Li, Kai Yuan Cao, Chen Qiang Mo, Shuang Jian Jiang, Jin Cheng Pan, Zong Ren Wang, Huan Yi Lin, Dao Hu Wang & Shao Peng Qiu. (2018)
ZEB
1‐mediated vasculogenic mimicry formation associates with epithelial–mesenchymal transition and cancer stem cell phenotypes in prostate cancer
. Journal of Cellular and Molecular Medicine 22:8, pages 3768-3781.
Crossref
Crossref
Wenxue Zhang, Ping Zhou, Ai Meng, Rongxin Zhang & Yan Zhou. (2018)
Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma
via
decreasing MMP-2 and inducing mesenchymal-to-epithelial transition
. Journal of Cellular and Molecular Medicine 22:3, pages 1743-1754.
Crossref
Crossref
Xiaoshu Zhou, Runxia Gu, Xiaoming Han, Gang Wu & Junli Liu. (2017) Cyclin-dependent kinase 5 controls vasculogenic mimicry formation in non-small cell lung cancer via the FAK-AKT signaling pathway. Biochemical and Biophysical Research Communications 492:3, pages 447-452.
Crossref
Crossref
Joseph Di Michele, Fabio Rotondo, Kalman Kovacs, Luis V. Syro, George M. Yousef, Michael D. Cusimano & Antonio Di Ieva. (2017) Vasculogenic Mimicry in Clinically Non-functioning Pituitary Adenomas: a Histologic Study. Pathology & Oncology Research 23:4, pages 803-809.
Crossref
Crossref
Yanwei Shen, Jianfeng Quan, Mengying Wang, Shuting Li, Jiao Yang, Meng Lv, Zheling Chen, Lingxiao Zhang, Xiaoai Zhao & Jin Yang. (2017) Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer. Oncotarget 8:34, pages 56408-56416.
Crossref
Crossref
Agnieszka Knopik-Skrocka, Patrycja Kręplewska & Donata Jarmołowska-Jurczyszyn. (2017) Tumor Blood Vessels and Vasculogenic Mimicry – Current Knowledge and Searching for New Cellular/Molecular Targets of Anti-Angiogenic Therapy. Advances in Cell Biology 5:1, pages 50-71.
Crossref
Crossref
Jine Yang, Yang Lu, Ying-Ying Lin, Zhi-Yuan Zheng, Jian-Hong Fang, Shuai He & Shi-Mei Zhuang. (2016) Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma. Cancer Letters 383:1, pages 18-27.
Crossref
Crossref
Wenchen Gong, Baocun Sun, Xiulan Zhao, Danfang Zhang, Junying Sun, Tieju Liu, Qiang Gu, Xueyi Dong, Fang Liu, Yong Wang, Xian Lin & Yanlei Li. (2016) Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway. Oncotarget 7:43, pages 70152-70167.
Crossref
Crossref
J. P. Yang, Y. D. Liao, D. M. Mai, P. Xie, Y. Y. Qiang, L. S. Zheng, M. Y. Wang, Y. Mei, D. F. Meng, L. Xu, L. Cao, Q. Yang, X. X. Yang, W. B. Wang, L. X. Peng, B. J. Huang & C. N. Qian. (2016) Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis. Angiogenesis 19:2, pages 191-200.
Crossref
Crossref
Wenming Liu, Mei Meng, Bin Zhang, Longsheng Du, Yanyan Pan, Ping Yang, Zhenlun Gu, Quansheng Zhou & Zhifei Cao. (2015) Dehydroeffusol effectively inhibits human gastric cancer cell-mediated vasculogenic mimicry with low toxicity. Toxicology and Applied Pharmacology 287:2, pages 98-110.
Crossref
Crossref
Yanlei Li, Baocun Sun, Xiulan Zhao, Danfang Zhang, Xudong Wang, Dongwang Zhu, Zhihong Yang, Zhiqiang Qiu & Xinchao Ban. (2015) Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer. Experimental and Molecular Pathology 98:2, pages 136-144.
Crossref
Crossref
Danfang Zhang, Baocun Sun, Xiulan Zhao, Yuemei Ma, Ru Ji, Qiang Gu, Xueyi Dong, Jing Li, Fang Liu, Xiaohua Jia, Xue Leng, Chong Zhang, Ran Sun & Jiadong Chi. (2014) Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer. Molecular Cancer 13:1.
Crossref
Crossref
Cecilia Lezcano, Sonja Kleffel, Nayoung Lee, Allison R Larson, Qian Zhan, Andrew DoRosario, Linda C Wang, Tobias Schatton & George F Murphy. (2014) Merkel cell carcinoma expresses vasculogenic mimicry: demonstration in patients and experimental manipulation in xenografts. Laboratory Investigation 94:10, pages 1092-1102.
Crossref
Crossref
Min Huang, Yiquan Ke, Xinlin Sun, Li Yu, Zhilin Yang, Yonghong Zhang, Mouxuan Du, Jihui Wang, Xiao Liu & Shuyun Huang. (2014) Mammalian target of rapamycin signaling is involved in the vasculogenic mimicry of glioma via hypoxia-inducible factor-1α. Oncology Reports.
Crossref
Crossref
Yue Li, Weiwei Cai, Qingqing Yi, Fengshan Xie, Yanling Liu, Bin Du, Lei Feng & Liying Qiu. (2014) Lipid droplets may lay a spacial foundation for vasculogenic mimicry formation in hepatocellular carcinoma. Medical Hypotheses 83:1, pages 56-59.
Crossref
Crossref
Fei Luo, Kuo Yang, Ran-lu Liu, Chao Meng, Rui-Feng Dang & Yong Xu. (2014) Formation of vasculogenic mimicry in bone metastasis of prostate cancer: Correlation with cell apoptosis and senescence regulation pathways. Pathology - Research and Practice 210:5, pages 291-295.
Crossref
Crossref
Liang Qin, Ye Ren, An-Min Chen, Feng-Jing Guo, Fei Xu, Chen Gong, Peng Cheng, Yu Du & Hui Liao. (2014) Peroxisome proliferator-activated receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway. Molecular Medicine Reports.
Crossref
Crossref
Qingmin Sun, Xi Zou, Ting Zhang, Jian Shen, Yongxiang Yin & Jingying Xiang. (2014) The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer. Gynecologic Oncology 132:3, pages 730-738.
Crossref
Crossref
Li Zhang, Po Ding, Hongcheng Lv, Dan Zhang, Guang Liu, Zhengduo Yang, Yan Li, Jun Liu & Shiwu Zhang. (2014) Number of Polyploid Giant Cancer Cells and Expression of EZH2 Are Associated with VM Formation and Tumor Grade in Human Ovarian Tumor. BioMed Research International 2014, pages 1-9.
Crossref
Crossref
Yang Qu, Li Zhang, Zhe Rong, Tao He & Sai Zhang. (2013) Number of glioma polyploid giant cancer cells (PGCCs) associated with vasculogenic mimicry formation and tumor grade in human glioma. Journal of Experimental & Clinical Cancer Research 32:1.
Crossref
Crossref
Zhifei Cao, Meimei Bao, Lucio Miele, Fazlul H. Sarkar, Zhiwei Wang & Quansheng Zhou. (2013) Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: A systemic review and meta-analysis. European Journal of Cancer 49:18, pages 3914-3923.
Crossref
Crossref
Zhifei Cao, Bingxue Shang, Gaochuan Zhang, Lucio Miele, Fazlul H. Sarkar, Zhiwei Wang & Quansheng Zhou. (2013) Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1836:2, pages 273-286.
Crossref
Crossref
ZhiFei Cao, Ping Yang & QuanSheng Zhou. (2013) Multiple biological functions and pharmacological effects of lycorine. Science China Chemistry 56:10, pages 1382-1391.
Crossref
Crossref
Zhifei Cao, Di Yu, Shilong Fu, Gaochuan Zhang, Yanyan Pan, Meimei Bao, Jian Tu, Bingxue Shang, Pengda Guo, Ping Yang & Quansheng Zhou. (2013) Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. Toxicology Letters 218:2, pages 174-185.
Crossref
Crossref
Sarah Shigdar, Liang Qiao, Shu-Feng Zhou, Dongxi Xiang, Tao Wang, Yong Li, Lee Yong Lim, Lingxue Kong, Lianhong Li & Wei Duan. (2013) RNA aptamers targeting cancer stem cell marker CD133. Cancer Letters 330:1, pages 84-95.
Crossref
Crossref